ARCHIVES

Techniclone Wins Patent For Tumor Necrosis Therapy.

This article is from The Cancer Letter archive.

Vol. 26 No. 08 | February 25, 2000

Download PDF Visit The Full Archive

Related Articles

Adjuvant Chemotherapy Unneeded In Children with Low-Risk Disease

March 29, 2013

Breast Asymmetry Predicts Breast Cancer, Study Finds

March 31, 2006

DCPC Advisors Okay Omnibus Prevention Program Announcement

January 24, 1992

Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering

September 3, 2010

Cancer Prevention; BCPT Enrollment Final At 13,000 After 5 Years

July 4, 1997

In Brief: New DCCP Director To BE Named Soon; Creech, Owens Head AACR, ASC; Carbone, Moertel Next

April 14, 1978